Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech Filtered by asset EHC
Coverage 92,422 Raw stories ingested 7,968 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 51s ago
  • FMP Forex News Fetch every 5 min 1m ago
  • CoinGecko News Fetch every 5 min 1m ago
  • FIO Stock News Fetch every 10 min 5m ago
  • Patria Stock News Fetch every 10 min 5m ago
  • Editorial rewrite Rewrite every minute 51s ago
  • Asset sync Assets every 1 hour 15m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Language
Relevance
Clear
Details Date Content Source Relevance
2026-07-23 12:50 2d ago
2026-07-23 08:00 3d ago
Encompass Health zvyšuje čtvrtletní dividendu na 0,21 USD
EHC Encompass Health Corp
FMP Stock News 88
Original source text
, /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced that its board of directors approved an increase of $0.02 in the Company's quarterly dividend and declared a quarterly cash dividend on its common stock of $0.21 per share, payable on Oct. 15, 2026, to holders of record on Oct. 1, 2026.

About Encompass Health 
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 176 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from major injuries or illnesses, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized by Newsweek as America's Most Awarded Leader in Inpatient Rehabilitation and is ranked among Fortune's World's Most Admired Companies™ and Forbes' America's Best Companies. It is also recognized by Becker's Healthcare and Modern Healthcare as a top healthcare employer. For more information, visit encompasshealth.com and follow us on our newsroom, X, Instagram and Facebook.

From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.

Forward-looking statements 
Statements contained in this press release which are not historical facts, such as the timing and amounts of dividends, are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking statements speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking statements, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, a decision by the board of directors to change the dividend rate in the future; the legal, regulatory and administrative developments that occur at the federal, state and local levels; general conditions in the economy and capital markets, including any instability or uncertainty related to armed conflict or an act of terrorism, governmental impasse over approval of the United States federal budget, an increase in the debt ceiling, or an international sovereign debt crisis; Encompass Health's ability to comply with extensive, complex, and ever-changing regulations in the healthcare industry; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10‑K for the year ended December 31, 2025, and Form 10-Q for the quarter ended Mar. 31, 2026.

Media contact:
Polly Manuel | 205-970-5912
[email protected]

Investor relations contact:
Mark Miller | 205-970-5860
[email protected]

SOURCE Encompass Health Corp.
2026-06-29 20:16 26d ago
2026-06-29 14:41 26d ago
Encompass Health zvýšila tržby, upravené EBITDA i výhled EPS
EHC Encompass Health Corp
FMP Stock News 78
Original source text
Key Takeaways EHC's growth story now hinges on expanding capacity efficiently to capture rising patient referrals.EHC opened a 49-bed hospital and added 44 beds in Q1 2026, with more expansions planned this year.EHC lifted 2026 adjusted EPS guidance after Q1 revenues rose 9% and adjusted EBITDA increased 11.2%. Encompass Health Corporation (EHC - Free Report) has reached an interesting point in its growth story. Demand is no longer the primary metric to watch. Supported by an aging U.S. population, the need for inpatient rehabilitation services continues to grow. Now the key question hinges on scale: Can EHC expand capacity fast enough to meet that demand?

Many of its hospitals are currently operating at high occupancy levels. To address this, management has changed its strategy. Instead of waiting for facilities to reach near-full capacity, it is now launching expansion projects earlier. This proactive approach brings new beds online before capacity becomes a constraint, helping the company capture more patient referrals.

We are already seeing this plan in action. In the first quarter of 2026, EHC opened a new 49-bed hospital in South Carolina and added 44 beds to existing locations. By the end of the year, it plans to open eight more hospitals and add about 175 beds. EHC has 11 additional hospitals in its development pipeline and plans to introduce a smaller hospital design in 2027 to better serve crowded, fast-growing markets.

EHC's expansion strategy is beginning to translate into stronger financial performance. First-quarter 2026 revenues rose 9% and adjusted EBITDA increased 11.2%, prompting management to raise its 2026 adjusted EPS guidance to $5.89-$6.11 from $5.81-$6.10. The investment thesis now depends less on demand and more on execution. Successfully bringing new capacity online while maintaining operational efficiency could support sustained earnings growth over the long run.

How Are EHC's Peers Positioned?Encompass Health is not alone in expanding capacity to meet rising healthcare demand. Medical sector peers like Select Medical Holdings Corporation (SEM - Free Report) and HCA Healthcare, Inc. (HCA - Free Report) are also investing in new facilities and hospital expansion to support long-term growth.

Select Medical is also expanding its inpatient rehabilitation footprint through new hospitals and joint ventures with health systems. Select Medical continues to strengthen its rehabilitation network to meet rising demand for post-acute care.

HCA Healthcare is also expanding its hospital network through new facilities and capacity additions to meet rising healthcare demand. HCA Healthcare continues to invest in its acute-care footprint, reinforcing capacity expansion as a key long-term growth strategy.

EHC’s Price Performance, Valuation & EstimatesShares of Encompass Health have lost 4.5% year to date against the industry’s 14.3%. growth.

Image Source: Zacks Investment Research

From a valuation standpoint, EHC trades at a forward price-to-earnings ratio of 16.33X compared with the industry average of 18.08X. Encompass Health carries a Value Score of B.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for EHC’s 2026 earnings is pegged at $5.97 per share, implying a 9.54% increase from the year-ago period’s level.

Image Source: Zacks Investment Research

Encompass Health currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.